|
|
№3 (приложение) / 2023
|
|
Alieva A.M., Teplova N.V., Butenko A.V., Averin E.E., Akhmedova M.F., Shikhova Yu.A., Valiev R.K., Saryev M.N., Kotikova I.A., Nikitin I.G.
MicroRNA-1 and microRNA-133: Small moleculesof great importance in the aspect of cardiovascular diseases
|
№2 / 2023
|
|
Roytberg G.E., Slastnikova I.D., Sharkhun O.O., Davydova A.S.
Value of cardiovascular risk factors in pre-test assessment of coronary heart disease
|
№1 / 2023
|
|
|
№10 (приложение) / 2022
|
|
|
№10 (приложение) / 2022
|
|
Markelova O.A., Vezikova N.N., Egorova I.S., Koryakova N.V.
Clinical and laboratory features of hospitalized patients with COVID-19 infection and coronary heart disease
|
№10 / 2022
|
|
Suvorova N.A., Gordeev I.G., Luchinkina E.E.
Osteopontin in chronic obstructive pulmonary disease patients as a predictor of cardiovascular events
|
№9 / 2022
|
|
Budnevsky A.V., Ovsyannikov E.S., Nekhaenko N.E., Ostroushko N.I., Simion A.Yu., Martynov A.I.
Influence of anemic syndrome correction on the course of coronary heart disease in outpatient practice
|
№8 / 2022
|
|
Alieva A.M., Teplova N.V., Ettinger O.A., Reznik E.V., Baykova I.E., Sarakaeva L.R., Shnahova L.M., Arakelyan R.A., Valiev R.K., Nikitin I.G.
The role of interleukin 12 in the development of cardiovascular diseases
|
№6 / 2022
|
|
Simion A.Yu., Ovsyannikov E.S., Drobysheva E.S.
Influence of anemic syndrome in patients with coronary heart disease on the main parameters of quality of life
|
№4 (приложение) / 2022
|
|
Vasilyeva L.V., Suslova E.Yu., Gosteva E.V.
Pathogenic factors of Helicobacter pylori in patients with coronary heart disease in combination with peptic ulcer
|
№4 (приложение) / 2022
|
|
Lyamina N.P.
Modern strategy of anti-ischemic therapy for patients with chronic coronary syndromes
|
№8 / 2021
|
Русский
